TickerFacts.

Palisade Bio, Inc. (PALI): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2020-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$12.19M
Year ended 2024-12-31
2009-12-31: -$5.23M2010-12-31: -$10.06M2011-12-31: -$8.29M2012-12-31: -$8.52M2013-12-31: -$10.72M2014-12-31: -$11.91M2015-12-31: -$19.11M2016-12-31: -$15.71M2017-12-31: -$13.43M2018-12-31: -$7.69M2020-12-31: -$4.77M2021-12-31: -$14.77M2022-12-31: -$13.37M2023-12-31: -$11.14M2024-12-31: -$12.19M-$12.19M
2009-12-31 Free Cash Flow (USD) 2024-12-31
Period endedFree Cash FlowChange YoYSource filing
2024-12-31-$12.19Mn/m2026-03-20, From 2024-01-01
2023-12-31-$11.14Mn/m2025-03-24, From 2023-01-01
2022-12-31-$13.37Mn/m2024-03-26, From 2022-01-01
2021-12-31-$14.77Mn/m2023-03-22, From 2021-01-01
2020-12-31-$4.77Mn/c2022-03-17, From 2020-01-01
No annual figure between 2018-12-31 and 2020-12-31.
2018-12-31-$7.69Mn/m2020-03-27, From 2018-01-01
2017-12-31-$13.43Mn/m2019-03-22, From 2017-01-01
2016-12-31-$15.71Mn/m2018-04-02, From 2016-01-01
2015-12-31-$19.11Mn/m2017-03-23, From 2015-01-01
2014-12-31-$11.91Mn/m2016-03-14, From 2014-01-01
2013-12-31-$10.72Mn/m2016-03-14, From 2013-01-01
2012-12-31-$8.52Mn/m2015-03-16, From 2012-01-01
2011-12-31-$8.29Mn/m2014-03-10, From 2011-01-01
2010-12-31-$10.06Mn/m2012-03-30, From 2010-01-01
2009-12-31-$5.23Mn/a2012-03-30, From 2009-01-01